BSE Live
Jan 09, 16:01Prev. Close
66.86
Open Price
66.82
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 09, 15:57Prev. Close
67.85
Open Price
65.51
Bid Price (Qty.)
69.37 (653)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Aarey Drugs and Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 28.45 | 28.05 | 25.38 | 25.38 | 23.38 | |
| Total Share Capital | 28.45 | 28.05 | 25.38 | 25.38 | 23.38 | |
| Reserves and Surplus | 107.51 | 102.25 | 89.71 | 88.25 | 75.48 | |
| Total Reserves and Surplus | 107.51 | 102.25 | 89.71 | 88.25 | 75.48 | |
| Total Shareholders Funds | 138.48 | 132.77 | 117.41 | 113.64 | 98.86 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 1.99 | 3.22 | 4.36 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.92 | 0.75 | 1.42 | 1.46 | 1.56 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 2.91 | 3.97 | 5.78 | 1.46 | 1.56 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 32.87 | 28.13 | 33.36 | 14.16 | 18.02 | |
| Trade Payables | 102.54 | 128.94 | 127.33 | 109.66 | 110.34 | |
| Other Current Liabilities | 11.07 | 6.74 | 3.96 | 3.63 | 0.78 | |
| Short Term Provisions | 2.73 | 2.74 | 3.49 | 2.62 | 3.47 | |
| Total Current Liabilities | 149.21 | 166.55 | 168.14 | 130.08 | 132.61 | |
| Total Capital And Liabilities | 290.59 | 303.29 | 291.32 | 245.17 | 233.04 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 16.22 | 12.96 | 13.94 | 14.47 | 14.26 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 16.22 | 12.96 | 13.94 | 14.47 | 14.26 | |
| Non-Current Investments | 2.12 | 1.38 | 0.40 | 0.40 | 0.40 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.98 | 0.71 | 0.78 | 3.98 | 0.00 | |
| Other Non-Current Assets | 5.67 | 5.66 | 5.60 | 0.00 | 0.00 | |
| Total Non-Current Assets | 24.98 | 20.71 | 20.72 | 18.85 | 14.66 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 45.48 | 34.68 | 28.82 | 13.68 | 18.46 | |
| Trade Receivables | 133.46 | 184.48 | 189.78 | 136.28 | 162.01 | |
| Cash And Cash Equivalents | 1.47 | 1.59 | 0.71 | 0.19 | 0.65 | |
| Short Term Loans And Advances | 29.56 | 15.51 | 9.01 | 0.02 | 0.02 | |
| OtherCurrentAssets | 55.63 | 46.32 | 42.29 | 76.14 | 37.23 | |
| Total Current Assets | 265.61 | 282.59 | 270.61 | 226.32 | 218.38 | |
| Total Assets | 290.59 | 303.29 | 291.32 | 245.17 | 233.04 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 11.08 | 5.66 | 21.70 | 30.10 | 1.75 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 2.98 | 1.41 | 2.37 | 0.93 | 0.30 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 2.80 | 2.80 | 2.80 | 2.80 | 2.80 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 2.12 | 1.38 | 0.40 | 0.40 | 0.40 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
14.11.2025
Aarey Drugs Standalone September 2025 Net Sales at Rs 84.16 crore, down 19.96% Y-o-Y
21.11.2024
Aarey Drugs Standalone September 2024 Net Sales at Rs 105.14 crore, up 81.81% Y-o-Y
19.08.2024
Aarey Drugs Standalone June 2024 Net Sales at Rs 126.91 crore, up 149.06% Y-o-Y
07.06.2024
Aarey Drugs Standalone March 2024 Net Sales at Rs 210.35 crore, up 32.98% Y-o-Y